AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

European Disease Registry on Retinopathy of Prematurity (ROP)

Recruitingn/aAges any - anyAllUniversity Medicine Greifswald
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The EU-ROP registry is a European wide multicenter non-interventional observational registry study intended to run open-ended in as many countries as possible including infants treated for retinopathy of prematurity irrespective of the used treatment modality. The registry is strictly observational; only clinical routine data is collected, no study-specific examinations or interventions are to be performed. The aim of the EU-ROP registry is to collect information on as many patients as possible treated for ROP in Europe. Both the number of study centers as well as the number of patients to be included into the registry are not limited. The primary objective is to describe the typical clinical features of infants with severe ROP, variations in phenotype, and the clinical progression of the disease over time (natural history) in different European countries as well as to study treatment

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * ROP requiring treatment according to the respective national ROP screening and treatment guidelines Exclusion Criteria: * Denial or absence of consent for documentation and electronic storage of personal data by parents or legal guardians
๐Ÿ’Š

What it tests

  • Registry of preterm born infants with treatment-requiring ROP
๐Ÿ“

Where

59 sites
University Eye Hospital Salzburg
Salzburg, Austria
University Hospital Saint George
Plovdiv, Bulgaria
Acibadem City Clinic Tokuda Hospital
Sofia, Bulgaria
University Eye Hospital Alexandrovska
Sofia, Bulgaria
University Eye Hospital Tartu
Tartu, Estonia
Hospital Rothschild
Paris, France
University Eye Hospital
Aachen, Germany
University Eye Hospital Helios
Berlin, Germany

โ€ฆand 51 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy